Re-initiation of biologics after the development of tuberculosis under anti-TNF therapy
Crossref DOI link: https://doi.org/10.1007/s00296-016-3575-3
Published Online: 2016-10-03
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ozguler, Yesim
Hatemi, Gulen
Ugurlu, Serdal
Seyahi, Emire
Melikoglu, Melike
Borekci, Sermin
Atahan, Ersan
Ongen, Gul
Hamuryudan, Vedat
License valid from 2016-10-03